Emtora Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Emtora Biosciences's estimated annual revenue is currently $387.5k per year.
- Emtora Biosciences's estimated revenue per employee is $77,500
Employee Data
- Emtora Biosciences has 5 Employees.
- Emtora Biosciences grew their employee count by 0% last year.
Emtora Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
Emtora Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.5M | 16 | 45% | N/A | N/A |
#2 | $13.8M | 89 | -7% | N/A | N/A |
#3 | $18.6M | 120 | 3% | $1.8M | N/A |
#4 | $0.9M | 6 | -40% | N/A | N/A |
#5 | $4.2M | 27 | 0% | N/A | N/A |
#6 | $3.4M | 22 | 47% | N/A | N/A |
#7 | $9.6M | 62 | 29% | N/A | N/A |
#8 | $0.9M | 6 | 20% | N/A | N/A |
#9 | $1.7M | 11 | 10% | N/A | N/A |
#10 | $15.2M | 98 | -8% | N/A | N/A |
What Is Emtora Biosciences?
Emtora Biosciences is a life science company developing a novel formulation of rapamycin, eRapa™, for use in preventing the onset and recurrence of cancer. A Phase 1b safety and dosing clinical trial is underway in early stage prostate cancer patients. A pilot efficacy study in Familial Adenomatous Polyposis (FAP) is planned for late 2019.
keywords:N/A
N/A
Total Funding
5
Number of Employees
$387.5k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Antonio
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 5 | -17% | N/A |
#2 | $0.7M | 5 | 0% | N/A |
#3 | $0.5M | 5 | -17% | N/A |
#4 | $0.4M | 5 | 0% | N/A |
#5 | $0.4M | 5 | -29% | N/A |